224 related articles for article (PubMed ID: 27121245)
1. Myasthenia gravis induced by nivolumab therapy in a patient with non-small-cell lung cancer.
Polat P; Donofrio PD
Muscle Nerve; 2016 Sep; 54(3):507. PubMed ID: 27121245
[No Abstract] [Full Text] [Related]
2. Relapsed Myasthenia Gravis after Nivolumab Treatment.
Mitsune A; Yanagisawa S; Fukuhara T; Miyauchi E; Morita M; Ono M; Tojo Y; Ichinose M
Intern Med; 2018 Jul; 57(13):1893-1897. PubMed ID: 29434145
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer.
Loochtan AI; Nickolich MS; Hobson-Webb LD
Muscle Nerve; 2015 Aug; 52(2):307-8. PubMed ID: 25759003
[No Abstract] [Full Text] [Related]
4. Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma.
Shirai T; Sano T; Kamijo F; Saito N; Miyake T; Kodaira M; Katoh N; Nishie K; Okuyama R; Uhara H
Jpn J Clin Oncol; 2016 Jan; 46(1):86-8. PubMed ID: 26491202
[TBL] [Abstract][Full Text] [Related]
5. [Myasthenia gravis induced by inmuno checkpoints inhibitors: first case report secondary to avelumab therapy and review of published cases].
Reyes-Bueno JA; Rodriguez-Santos L; Serrano-Castro PJ
Rev Neurol; 2019 Apr; 68(8):333-338. PubMed ID: 30963530
[TBL] [Abstract][Full Text] [Related]
6. Benign form of myasthenia gravis after nivolumab treatment.
Sciacca G; Nicoletti A; Rampello L; Noto L; Parra HJ; Zappia M
Muscle Nerve; 2016 Sep; 54(3):507-9. PubMed ID: 27287688
[No Abstract] [Full Text] [Related]
7. New onset myasthenia gravis in a patient with non small cell lung cancer treated with lorlatinib a novel anti-cancer agent.
Desai A; Sriwastava S; Gadgeel SM; Lisak RP
J Neurol Sci; 2018 Sep; 392():100-101. PubMed ID: 30031992
[No Abstract] [Full Text] [Related]
8. Nivolumab-induced myasthenia gravis in a patient with squamous cell lung carcinoma: Case report.
Chen YH; Liu FC; Hsu CH; Chian CF
Medicine (Baltimore); 2017 Jul; 96(27):e7350. PubMed ID: 28682883
[TBL] [Abstract][Full Text] [Related]
9. [A case of myasthenia gravis and myositis induced by nivolumab].
Konoeda F; Suzuki S; Nishimoto Y; Hoshino H; Takagi M
Rinsho Shinkeigaku; 2017 Jul; 57(7):373-377. PubMed ID: 28674287
[TBL] [Abstract][Full Text] [Related]
10. Coexisting myasthenia gravis, myositis, and polyneuropathy induced by ipilimumab and nivolumab in a patient with non-small-cell lung cancer: A case report and literature review.
Chen JH; Lee KY; Hu CJ; Chung CC
Medicine (Baltimore); 2017 Dec; 96(50):e9262. PubMed ID: 29390370
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis induced by nivolumab in patients with non-small-cell lung cancer: a case report and literature review.
Hasegawa Y; Kawai S; Ota T; Tsukuda H; Fukuoka M
Immunotherapy; 2017 Aug; 9(9):701-707. PubMed ID: 28649876
[TBL] [Abstract][Full Text] [Related]
12. Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan.
Suzuki S; Ishikawa N; Konoeda F; Seki N; Fukushima S; Takahashi K; Uhara H; Hasegawa Y; Inomata S; Otani Y; Yokota K; Hirose T; Tanaka R; Suzuki N; Matsui M
Neurology; 2017 Sep; 89(11):1127-1134. PubMed ID: 28821685
[TBL] [Abstract][Full Text] [Related]
13. Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non-small cell lung cancer.
Mahjoubi L; Gazzah A; Marabelle A; Le Roy Ladurie F; Lambotte O; Caramella C; Adam J; Besse B; Soria JC
Eur J Cancer; 2017 Nov; 85():155-157. PubMed ID: 28917814
[No Abstract] [Full Text] [Related]
14. Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer.
Rampinelli C; Spitaleri G; Passaro A; Pochesci A; Ancona E; De Marinis F
Am J Respir Crit Care Med; 2017 Nov; 196(10):1349-1350. PubMed ID: 28910131
[No Abstract] [Full Text] [Related]
15. [Psoriasis and Psoriatic Arthritis Induced by Nivolumab in a Patient with Advanced Non-Small-Cell Lung Cancer].
Sugiura Y; Fujimoto H; Yamamoto M; Nomura H; Hashizume T; Kawai O; Araki N; Kawakami K; Sueki H; Fusegawa H; Ohkubo Y; Nemoto E
Gan To Kagaku Ryoho; 2017 Sep; 44(9):787-789. PubMed ID: 28912410
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis and psoriatic arthritis induced by nivolumab in a patient with advanced lung cancer.
Law-Ping-Man S; Martin A; Briens E; Tisseau L; Safa G
Rheumatology (Oxford); 2016 Nov; 55(11):2087-2089. PubMed ID: 27436004
[No Abstract] [Full Text] [Related]
17. Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient With Advanced Non-Small Cell Lung Cancer: A Case Report.
Syrigos K; Tsagouli S; Grapsa D
Ann Intern Med; 2016 Dec; 165(12):894-895. PubMed ID: 27992901
[No Abstract] [Full Text] [Related]
18. Long-Lasting Response to Nivolumab and Immune-Related Adverse Events in a Nonsquamous Metastatic Non-Small Cell Lung Cancer Patient.
Ricciuti B; Metro G; Baglivo S; Colabrese D; Chiari R; Bennati C; Paglialunga L
J Thorac Oncol; 2017 May; 12(5):e51-e55. PubMed ID: 28434516
[No Abstract] [Full Text] [Related]
19. Nivolumab: a review in advanced squamous non-small cell lung cancer.
Keating GM
Drugs; 2015 Nov; 75(16):1925-34. PubMed ID: 26514815
[TBL] [Abstract][Full Text] [Related]
20. [Unexpected adverse events of immunotherapies in non-small cell lung cancer: About 2 cases].
de Chabot G; Justeau G; Pinquié F; Nadaj-Pakleza A; Hoppé E; Hureaux J; Urban T
Rev Pneumol Clin; 2017 Dec; 73(6):326-330. PubMed ID: 29169677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
